Will Insurance Cover GLP-1 for Weight Loss?

Last reviewed: October 20, 2025 • Evidence-based editorial

Confused about GLP-1 insurance coverage? This guide explains eligibility, prior authorization, and real plan examples so you can choose the smartest path—insurance or cash-pay.^1–3

GLP-1 Insurance Coverage: Basics

Two different indications. Plans often treat GLP-1s for diabetes (e.g., Ozempic) differently from weight-loss (e.g., Wegovy). Diabetes use is more likely to be covered; weight-loss use is commonly excluded or restricted to tight criteria, employer opt-ins, or specialty programs.^1–3

Your plan’s rules govern everything. Even within the same insurer, each plan can set unique coverage, prior authorization (PA) criteria, and step therapy. Federal employee plans (FEHB), large employers, small-group plans, ACA marketplace plans, and Medicaid each have distinct policies and budgets—so your results can differ dramatically from a friend’s on the “same” insurer.^1–3

Coverage is plan-specific. Even if a plan “covers GLP-1s,” you may face PA, step therapy, quantity limits, and renewals—coverage doesn’t always mean affordable.

What Insurers Typically Require (for weight-loss use)

Medical eligibility. Adults usually must have BMI ≥30, or BMI ≥27 with a related condition (e.g., hypertension, sleep apnea). Some plans require documented lifestyle attempts (diet, activity, counseling) before GLP-1 approval.^2,3

Prior authorization. Your clinician submits weight/BMI, diagnoses, prior treatments, and the specific GLP-1 + dose. Plans often require step therapy (try/fail another medication) or proof of participation in a lifestyle program. PA is common even when a plan covers the drug class.^2,3

Renewals & progress checks. After an initial period (often 3–6 months), plans frequently require renewal based on progress (e.g., ≥5% weight loss by 3–6 months) and adherence.^2,3

Medicaid Snapshots: CA • NY • TX (illustrative)

California (Medi-Cal). Coverage for anti-obesity medications has shifted over budget cycles. California’s policy has been a moving target, with periods of expansion and pullbacks tied to cost controls; check the current Medi-Cal bulletin and formulary notes for exact criteria and any caps/renewals.^6,7

New York (NYRx). New York’s Medicaid pharmacy program has broadly excluded weight-loss indications for GLP-1 agonists in policy documents, while diabetes indications follow separate criteria. Always verify current NYRx drug class coverage updates before submitting a PA.⁴

Texas (Medicaid). Texas historically excluded weight-loss indications; more recent updates show limited coverage pathways (e.g., Wegovy with prior authorization) depending on the program and effective date. Review the most recent provider alerts and PA criteria for specifics.⁵

Employer & private plans: Why they differ so much

Employer carve-outs. Many employers opt out of weight-loss-drug coverage due to cost, even if their insurer offers it. FEHB (federal employees) documents have shown coverage pathways (with controls); other employers decide annually based on budget and clinical programs.^1,12

Insurer policies vs. plan design. Insurers like UnitedHealthcare or Aetna publish PA criteria and clinical notes, but your specific plan decides whether weight-loss coverage is “on” at all—and which GLP-1s are on formulary.^2,12,13

What this means for you. If your employer opted out, there’s no PA to submit for weight-loss use. Ask HR/benefits whether weight-loss GLP-1s are covered for the current plan year, and whether a rider or future plan option exists.^10,12

Prior Authorization: What to Expect (and how to speed it up)

• Before the visit: Gather BMI history, comorbidities, and prior attempts (diet, activity, medications, counseling).
• During the visit: Confirm which GLP-1 and dose your clinician will request; discuss step-therapy requirements.
• Document thoroughly: The PA should include diagnostics, prior therapies tried/failed, and program participation if required.^2,3
• Follow up: Ask the clinic who handles PAs and typical response times; calendar a check-in.

Cost math: Insurance vs. cash-pay (and when to switch)

Insurance path. When covered, you’ll typically pay a copay or coinsurance. But coinsurance on a high list price can exceed cash-pay. PA delays can also push treatment back by weeks.

Cash-pay path. Some patients choose a cash-pay telehealth program to begin treatment quickly and control costs (especially if their plan excludes weight-loss coverage). If you pursue insurance later, you can switch once PA is approved—or stay cash-pay if it’s cheaper overall.¹⁴

First-month vs ongoing. Budget for a higher Month-1 (initiation, labs, consult) and a different Month-2+ pattern (program + medication). Compare the full “all-in” cost of each path—not just the drug price.

Coverage is not the same as affordability. Run the math on copay/coinsurance vs. a transparent cash-pay program before you decide.

Appeals & Denials: Your Roadmap

1. Read the denial letter. It must state the reason and the next step (e.g., missing BMI, step therapy not met).
2. Fix the gap. Have your clinician update the PA with the required data (e.g., prior program documentation).
3. Ask for a peer-to-peer. Your clinician can speak with the plan’s medical reviewer to explain medical necessity.
4. File a level-1 appeal. Follow the plan’s instructions exactly (forms, deadlines).
5. External review (if eligible). Some plans must offer an independent review process after internal appeals.¹⁰

What to Ask Your Plan (copy-ready checklist)

• Does my plan cover weight-management medications (GLP-1s like Wegovy)?
• If yes, which drugs and doses are covered?
• Coverage criteria? (BMI, comorbidities, prior attempts, program requirements)
• Prior authorization needed? What docs are required?
• Step therapy rules? (Do I need to try another drug first?)
• Quantity/time limits or 3–6 month renewals?
• My cost (copay vs. coinsurance) and specialty pharmacy rules?
• If excluded, is there a rider or future plan option?
• Appeal process and timelines if denied?

Quick FAQ